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High intensity  focused  ultrasound  (HIFU)  is  a  non-invasive  medical  technology  for  ablation
of  body  tumors  [1].  The  fact  that  such  treatment  is  done  without  the  insertion  of  any  nee-
dles  into  tumors,  unlike  radiofrequency  (RF),  cryotherapy  or  microwave  ablation,  attracted
the  attention  of  many  physicians  and  scientists.  However,  for  any  medical  technology  to
get  fully  integrated  in  clinical  practice  essential  requirements  need  ﬁrst  to  be  fulﬁlled;MR  guided
interventional
procedures;
Ultrasonography;
Interventional
namely:  feasibility,  efﬁcacy  and  safety.  HIFU  has  proved  to  be  feasible  and  effective  for
treatment  of  body  tumors.  Many  reports  clearly  showed  signiﬁcant  clinical  and  laboratory
improvement  in  patients  treated  by  HIFU  [2,3].  Treatment  efﬁcacy  was  not  assessed  only
by  medical  imaging,  but  extended  also  to  conﬁrmation  and  characterization  of  the  HIFU
induced  tissue  damage  on  histology  [3,4].
The  ‘‘safety’’  issue  in  clinical  practice  usually  refers  to  the  concept  of  inducing  no
harm  or  unintended  damage  to  surrounding  structures.  In  this  context,  HIFU  appears  to
be  a  safe  technique  for  treatment  of  body  tumors.  In  their  study,  to  treat  patients  with
hepatocellular  carcinoma  (HCC)  adjacent  to  main  hepatic  blood  vessels,  Zhang  et  al.  [5]
reported  the  safety  of  HIFU  therapy  at  a  distance  less  than  1  cm  from  the  portal  vein,  infe-
rior  vena  cava  (IVC)  and  their  branches.  When  applied  correctly,  most  of  the  complications
associated  with  HIFU  therapy  are  in  the  form  of  edema  of  the  skin  and  subcutaneous  tissue
within  the  path  of  the  HIFU  beam.  These  events  are  frequently  encountered  and  usually
resolve  spontaneously,  therefore,  they  may  not  be  considered  a  serious  complication  of
HIFU  therapy  [6].  However,  for  evolving  medical  technologies  like  HIFU,  especially  in  the
ﬁeld  of  oncology,  the  deﬁnition  of  ‘‘safety’’  entails  other  considerations.  The  ability  to
precisely  monitor  the  treatment  process  is  an  essential  safety  determinant.  Underestima-
tion  of  the  extent  of  ablation  can  mislead  the  treating  physician,  getting  him  to  spend
more  time  trying  to  ablate  tissues  that  are  already  ablated.  This  leads  to  the  prolongation
of  the  already  known  lengthy  HIFU  ablation  sessions,  and  may  lead  to  overheating  that
increases  the  incidence  of  accidental  injury  of  nearby  vital  structures.  On  the  other  hand,
false  overestimation  of  the  extent  of  ablation  will  leave  the  physician  comfortable  that
the  whole  tumor  was  ablated,  while  in  fact  it  was  not.  This  will  be  translated  clinically
into  residual  viable  tumoral  tissue  in  later  follow-up.
To  help  solving  this  dilemma,  it  is  important  to  understand  how  and  why  this  problem
is  more  distinct  with  HIFU  than  with  any  other  ablation  technique.  It  is  also  helpful  to
understand  how  imaging  can  bring  in  answers  for  such  a problem.  Taking  RF  ablation  as
an  example,  during  ablation,  treating  physicians  get  instantaneous  feedback  regarding
changes  in  tissue  impedance  and  local  temperature  rise  in  vicinity  of  the  tip  of  the  RF
needle.  Analysis  of  these  data  gets  physicians  assured  that  satisfactory  tissue  ablation
was  achieved.  However,  with  HIFU  nothing  is  inserted  inside  the  tumor,  and  this  calls  for
advanced  feedback  mechanisms  to  evaluate  the  ablation  at  the  focus.  Here  comes  the
unique  role  that  medical  imaging  has  to  play  as  regards  to  HIFU  therapy.
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Magnetic  resonance  imaging  (MRI)  and  ultrasound  are
urrently  used  to  monitor  HIFU  therapy.  MRI  makes  use  of
hanges  in  the  proton  resonance  frequency  (PRF)  in  response
o  tissue  heating  to  convey  information  regarding  temper-
ture  changes  at  the  focus.  Shifts  in  PRF  were  found  to
orrelate,  in  most  cases,  with  temperature  rise  at  the  focus
sensitive  for  increments  of  about  1 ◦C)  [7].  Thus,  it  was  pos-
ible  to  translate  these  PRF  shifts  into  thermal  maps  that  can
rack  focal  temperature  rise  and  gives  clinically  accepted
ndicators  that  sufﬁcient  thermal  dose  has  been  delivered
o  ablate  the  tissue  at  the  focus.  In  addition  to  the  high-
esolution  imaging  that  MRI  provides,  we  believe  that  MR
hermometry  was  one  of  the  main  factors  that  contributed
or  the  US  Food  and  Drug  Administration  (FDA)  approval  of
he  only  two  FDA  approved  clinical  HIFU  applications  so  far:
blation  of  uterine  ﬁbroids  and  pain  palliation  from  bone
etastasis.  Though  the  concept  is  validated  and  already
n  clinical  use;  some  limitations  still  exist.  Thermal  maps
re  degraded  by  respiratory  movements  and  are  not  that
fﬁcient  to  track  temperature  changes  in  fat  [7,8].
On  the  other  side,  ultrasound  in  current  clinical  systems
ppears  to  be  defective  in  tracking  the  lethal  tempera-
ure  elevation  in  tissues,  due  to  the  absence  of  clinical
ltrasound  thermometry  so  far.  Instead,  ultrasound  mon-
toring  uses  changes  in  echogenicity  at  the  focus,  in  the
orm  of  hyper-echogenic  changes,  as  an  indication  of  tis-
ue  damage.  However,  the  exact  mechanism  by  how  these
yper-echogenic  changes  develop  is  still  questionable.  The
ost  acceptable  explanation  is  that  these  changes  reﬂect
ubble  activity  rather  than  mere  thermal  tissue  ablation
7].  This  may  explain  why  these  echogenic  changes  are
sually  transient  in  nature.  Moreover,  in  some  conditions
he  hyper-echogenic  changes  may  be  absent,  hardly  appre-
iable  or  even  relatively  delayed,  reﬂecting  the  fact  that
uch  echogenic  changes  may  indicate  cavitation  activity
ather  than  only  coagulative  necrosis  [7,9].  In  such  cases,
he  echogenic  changes  may  overestimate  the  size  of  the
IFU  lesion  and  can  be  pre-focal  in  location.  Some  infor-
ative  studies  were  published  correlating  the  extent  ofhese  echogenic  changes  to  the  extent  of  tissue  ablation,
s  inferred  from  follow-up  MRI  imaging  and  histology  [4,10].
e  may  share  the  idea  that  hyper-echogenic  changes  can  be
sed  to  indicate  and  localize  tissue  damage.  However,  we
Table  1  Main  differences  between  magnetic  resonance  and  u
Guidance  MRI  
Advantages  High  soft  tissue  resolution  and  tumor
characterization
Treatment  monitoring  MRI  thermometry:  changes  in  PRF  cor
with  localized  heating
Limitations  Temperature  maps  are  not  that  accur
and  are  degraded  by  respiratory  move
Cost-effectiveness  More  expensive  
FDA  approval Approved  for  ablation  of  uterine  ﬁbro
for  bone  metastasis
Main  applications  Uterine  ﬁbroids,  bone  metastasis  and
investigational  neurosurgery  applicati
MRI: Magnetic resonance imaging; PRF: proton resonance frequency; F
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trongly  believe  that  further  research  is  still  needed  before
ogmatic  statements  can  be  made  regarding  the  accuracy
f  using  these  echogenic  changes  to  precisely  estimate  the
ize  and  extent  of  actual  tissue  ablation.
In  view  of  the  aforementioned  facts  and  discussion,  an
mportant  question  comes  now  on  the  scene:  which  is  better
n  clinical  practice:  MRI  or  ultrasound  guided  HIFU?  Ironi-
ally,  though  the  differences  between  MRI  and  ultrasound
uidance  are  well  known  (Table  1),  no  clear  answer  is  avail-
ble  in  literature  despite  the  importance  of  the  question!
e  think  the  lack  of  a deﬁnitive  answer  may  be  attributed
o  the  fact  that  no  one  really  has  the  ‘‘right’’  one.  In  our
pinion,  the  ‘‘scientiﬁc’’  answer  to  such  a  question  should
ome  through  well-designed  comparative  studies.  However,
o  our  knowledge  and  in  our  opinion,  such  studies  are  not
urrently  available  and  will  not  be  available  soon,  since
ost  of  the  current  research  work  is  directed  to  validate  the
fﬁcacy  of  HIFU  for  clinical  applications  rather  than  to  com-
are  the  guidance  methods.  In  our  opinion,  two  main  factors
etermine  which  imaging  method  is  the  best.  The  ﬁrst  is  the
IFU  application  itself;  and  the  second  is  the  experience  of
he  operating  physicians.  Taking  liver  tumors  as  an  example,
ltrasound  guided  HIFU  has  the  upper  hand  so  far  because
igh-resolution  real-time  imaging  can  be  obtained  despite
espiratory  movements.  Such  movements  may  degrade  MRI
maging.  Though  some  ideas  are  proposed  on  the  MRI  side
o  overcome  this  problem  [8,11],  straightforward  analysis  of
he  literature  reveals  that  the  vast  majority  of  hepatic  inter-
entions  were  done  using  the  ultrasound  guided  machines.
Another  good  example  of  an  ultrasound  guided  HIFU
pplication  is  the  treatment  of  prostate  cancer.  The  treat-
ent  has  been  conducted  for  long  time  under  ultrasound
uidance  and  monitoring,  with  thousands  of  patients  being
reated  by  HIFU  either  as  a  salvage  treatment  after  radio-
herapy  [12]  or  in  the  form  of  whole  gland  ablation  for
ocalized  prostate  cancer  [13]. Recently,  MRI  guidance  was
ntroduced  for  ablation  of  prostate  cancer  [14],  however,
he  numbers  of  patients  treated  under  MRI  guidance  are  still
uch  lower  than  those  treated  under  ultrasound  guidance.ltrasound  imaging  guidance.
Ultrasound
Real-time  imaging  not  degraded  by
respiratory  movement
relates Hyper-echogenic  changes  reﬂecting
cavitation  activity  at  the  focus
ate  in  fat
ments
Echogenic  changes  may  be  delayed  or  even
pre-focal  in  location
Relatively  less  expensive
ids  and Not yet  approved
ons
Liver,  pancreas  and  prostate  tumors  as  well
as  uterine  ﬁbroids
DA: Food and Drug Administration.
On  the  other  hand,  other  applications  are  more  suitable
or  MRI  guided  HIFU.  Investigational  treatment  of  essen-
ial  tremors,  Parkinsonism  and  neuropathic  pain  through
ntact  skull  bone  is  exclusively  done  under  MRI  guidance.
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Palliation  of  pain  from  bone  metastasis  is  also  more  conve-
nient  under  MRI  guidance,  owing  to  the  high-resolution  MR
imaging  of  bone  and  nearby  neurovascular  bundle  as  com-
pared  to  ultrasound  [8].  In  between  both  extremes  come
some  other  applications,  like  treatment  of  uterine  ﬁbroids
that  can  be  done  under  MRI  or  ultrasound  guidance;  with
satisfactory  clinical  outcomes  [15,16].
Secondly,  in  oncology,  physicians  are  more  comfortable
with  MRI  than  with  other  imaging  modalities.  However,
clinical  outcomes  published  in  literature  regarding  treat-
ments  of  tumors  using  ultrasound  guided  HIFU  are  indeed
impressive  (Fig.  1).  These  studies  come  mostly  from  places
where  ultrasound  guided  HIFU  is  widely  used,  like  China  for
hepatic  tumors  [2,3]  and  France  for  prostate  cancer  ablation
[12,13].  This  highlights  the  fact  that  local  experience  with
the  available  systems  is  an  important  determinant  factor  for
which  guidance  method  is  more  convenient  or  preferred.
The  lack  of  ultrasound  thermometry  in  clinical  practice  so
far  is  an  important  factor  that  gives  an  advantage  for  MRI
guidance,  while  the  relative  low  cost  of  ultrasound  guid-
ance,  as  compared  to  MRI,  is  in  favor  of  ultrasound  guided
systems.
The  early  reports  for  clinical  application  of  HIFU  date
back  to  the  1950s.  However,  owing  to  lack  of  satisfactory
imaging  to  guide  and  monitor  the  treatment,  HIFU  remained
in  a  dark  cave  for  more  than  40  years!  In  the  second  half
of  the  1990s,  there  was  a  rediscovery  of  HIFU  for  clinical
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Figure 1. Post-contrast coronal MRI of a hepatic tumor treated by u
heterogonous contrast enhancement before treatment. B. After HIFU the
ablation.
(Photo courtesy: Dr. Hui Zhu) (re-printed with permission from Elsevier).571
pplications,  thanks  to  the  availability  of  MRI  and
igh-resolution  ultrasound  imaging.  Nowadays,  ambitious
esearch  work  is  conducted  to  provide  faster  multi-
eference  MRI  temperature  imaging  and  motion  tracking
echniques  to  overcome  the  artifacts  caused  by  respiratory
ovements  [8].  Furthermore,  MRI  thermometry  is  investi-
ated  to  provide  an  instantaneous  feedback  to  control  the
onication  power,  in  a  way  that  allows  for  delivery  of  enough
ower  to  induce  thermal  ablation  without  wasting  extra  time
r  energy  for  unnecessary  overheating.  This  technology  is
xpected  to  reduce  the  treatment  time  of  MRI  guided  HIFU
herapy  [8,17].
Other  feedback  criteria  from  ultrasound  imaging,  like
lastography  and  changes  in  speed  of  sound  secondary  to
ocal  temperature  elevation  [7],  are  investigated  to  provide
dditional  feedback  regarding  the  focal  thermal  ablation
ather  than  depending  only  on  the  hyper-echogenic  changes.
n  view  of  all  this  research  work,  we  are  optimistic  that
edical  imaging  will  provide  the  adequate  and  necessary
eedback  for  successful  HIFU  therapy.
HIFU  has  proved  itself  as  a  feasible,  efﬁcient  and  clini-
ally  safe  technology  for  ablation  of  body  tumors.  Nowadays,
hat  is  needed  from  medical  imaging  is  not  only  to  see
hat  is  going  on  at  the  focus,  but  also  to  accurately
uantify  the  extent  of  the  induced  damage.  This  may  be
he  hardest  challenge  ever  for  medical  imaging  as  regards
IFU.
ltrasound guided HIFU [1]. A. Right hepatic lobe tumor showing
rapy, no signiﬁcant enhancement is seen denoting adequate tumor
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